DCAF6

DCAF6 (NRIP) is a bifunctional protein that operates both as a substrate receptor within CRL4 (CUL4–DDB1–RBX1) E3 ubiquitin ligase complexes and as a Ca2+/calmodulin-responsive scaffold in striated muscle (PMID:26430214, PMID:36688959). As a DCAF, it assembles with CUL4A/CUL4B, DDB1, and RBX1 to direct polyubiquitination and degradation of specific substrates, including the transcriptional corepressors CtBP1 and CtBP2—whose loss dissociates the p300–FOXO3a complex to induce BBC3/PUMA and caspase-dependent apoptosis—and the PP2A scaffold subunit PPP2R1B (PMID:33913576, PMID:36688959). In the same ligase context it can also stabilize substrates by competition: DCAF6 displaces DDB2 from the AR–DDB2–DDB1–CUL4A complex to prevent androgen receptor ubiquitination and degradation in prostate cancer (PMID:28212551). Independently of its ligase role, DCAF6 binds calmodulin through its IQ domain in a calcium-dependent manner and acts downstream of Ca2+ signaling to activate calcineurin–NFATc1 and CaMKII pathways (PMID:21543494, PMID:26430214). At the Z-disc of skeletal and cardiac muscle it interacts with α-actinin 2 (ACTN2), promotes ACTN2-mediated F-actin bundling and ACTN2–CapZ association, and is required for normal sarcomere structure, mitochondrial respiration, muscle strength, and regeneration (PMID:26430214, PMID:31629737). Through calmodulin-dependent activation of calcineurin, DCAF6 dephosphorylates the HPV-16 E2 protein, blocking its polyubiquitination and stabilizing it (PMID:21543494).

1. 2011 High

   Established DCAF6/NRIP as a calcium-dependent calmodulin-binding protein that couples Ca2+ signaling to calcineurin activation and substrate stabilization, defining its scaffold/signaling arm.

   Evidence Reciprocal Co-IP in vivo and in vitro, IQ-domain mapping, calmodulin-binding and calcineurin phosphatase assays, ubiquitination assay with HPV-16 E2 as readout

   PMID:21543494

   Open questions at the time

   • Demonstrated in the context of a viral substrate (E2) rather than an endogenous one
   • Did not connect calmodulin-binding to a ubiquitin ligase function
2. 2015 High

   Placed DCAF6/NRIP at the muscle Z-disc and downstream of Ca2+ signaling, showing it activates calcineurin–NFATc1 and CaMKII pathways required for muscle strength, fatigue resistance, and regeneration in vivo.

   Evidence NRIP-knockout mice with grip-strength/fatigue testing, calmodulin Co-IP, calcineurin/CaMKII activity assays, myotube formation and gene expression analysis

   PMID:26430214

   Open questions at the time

   • Z-disc binding partner anchoring DCAF6 not identified
   • Did not address any E3 ligase activity
3. 2017 Medium

   Revealed DCAF6 can stabilize rather than degrade a substrate by competing with DDB2 for AR binding within the CUL4A–DDB1 complex, identifying a mechanism for AR protein stabilization in prostate cancer.

   Evidence Co-IP, competition binding assay, AR protein stability assay, IHC of prostate cancer tissues

   PMID:28212551

   Open questions at the time

   • Single lab with two orthogonal methods
   • Direct ubiquitination of AR by the competing complexes not fully resolved
4. 2019 High

   Defined the structural role of DCAF6 at the cardiac Z-disc, linking its interaction with ACTN2 and F-actin bundling to sarcomere integrity and mitochondrial respiratory function.

   Evidence Muscle-specific conditional KO (MCK-Cre::Dcaf6flox/flox), Co-IP, confocal/TEM imaging, F-actin bundling and mitochondrial respiration assays, mitoTEMPO/nicotinic acid rescue

   PMID:31629737

   Open questions at the time

   • Molecular basis of the mitochondrial defect (direct vs. structural) not fully separated
   • ACTN2 interaction interface not mapped
5. 2021 Medium

   Identified PPP2R1B as a CRL4A^DCAF6 ubiquitination substrate with USP5 as its deubiquitinase, and linked degradation-sensitizing PPP2R1B mutations to azoospermia.

   Evidence Co-IP, ubiquitination assay, Ppp2r1b-knockout mice, human patient sequencing

   PMID:33913576

   Open questions at the time

   • Single lab
   • Causality between PPP2R1B degradation and the azoospermia phenotype not directly demonstrated in vivo
6. 2023 High

   Defined the full CRL4^DCAF6 ligase composition (CUL4A/CUL4B, DDB1, RBX1) and a substrate-to-phenotype axis: CtBP1/2 degradation triggers p300–FOXO3a-dependent PUMA induction and apoptosis, druggable in an intervertebral disc degeneration model.

   Evidence Reciprocal Co-IP, in vitro and in vivo ubiquitination assays, CUL4–DDB1 inhibitor TSC01131, mouse chronic inflammation/IDD model, human IDD biopsies

   PMID:36688959

   Open questions at the time

   • DCAF degron motif recognized in CtBP1/2 not defined
   • Regulation of substrate selection between degradative and stabilizing modes unresolved

• How DCAF6 switches between its E3 ligase substrate-receptor role and its calmodulin-scaffold/Z-disc role, and what determines whether a bound partner is degraded versus stabilized, remains unresolved.
• No structural model of substrate recognition
• No unifying degron or recruitment logic across CtBP1/2, PPP2R1B, and AR
• Crosstalk between calmodulin binding and ligase assembly uncharacterized